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In many experimental models and clinical examples,
defects in the differentiation of the second heart field
(SHF) and heart outflow tract septation defects are
combined, although the mechanistic basis for this
relationship has been unclear. We found that as the
initial SHF population incorporates into the outflow
tract, it is replenished from the surrounding progen-
itor territory. In retinoic acid (RA) receptor mutant
mice, this latter process fails, and the outflow tract
is shortened and misaligned as a result. As an addi-
tional consequence, the outflow tract is misspecified
along its proximal-distal axis, which results in ectopic
expression of TGFb2 and ectopic mesenchymal
transformation of the endocardium. Reduction of
TGFb2 gene dosage in the RA receptor-deficient
background restores septation but does not rescue
alignment defects, indicating that excess TGFb
causes septation defects. This may be a common
pathogenic pathway when second heart field and
septation defects are coupled.
INTRODUCTION
The tissue of the first heart field will ultimately become the
myocardium and endocardium of the left ventricle and of
portions of both atrial chambers. The second heart field (SHF)
is a progenitor population of splanchnic and pharyngeal meso-
derm that is located dorsal to the pericardial cavity. SHF cells
are added progressively to both ends of the heart tube (Bucking-
ham et al., 2005; Horsthuis et al., 2009), in mouse during the
E8.0–10.5 period, fully constituting the right ventricle and outflow
tract (OFT) and contributing to portions of both atrial chambers at
the inflow region of the heart.
The OFT initially exits the heart solely from the right ventricle.
Through the continuing recruitment of tissue from the second
heart field, the OFT lengthens and repositions by E10.5–11.0 to
overlie the interventricular septum. Around E11.0–11.5, the
OFT becomes septated (divided) by the expansion and fusion
of cushions positioned on opposite sides of its inner wall to
form the ascending aorta and pulmonary trunk. Lengthening
and repositioning of the OFT in the period prior to septation is480 Developmental Cell 18, 480–485, March 16, 2010 ª2010 Elseviernecessary for the ascending aorta, once formed, to connect to
the left ventricle. Consequently, when development of the SHF
is compromised, alignment defects such as double outlet right
ventricle (DORV; the aorta and pulmonary trunk both exit from
the right ventricle) or overriding aorta (the aorta straddles the
interventricular septum) occur. Problems in SHF development
can in addition compromise the septation process, resulting
in a persisting single outflow vessel. This phenotype is often
called persistent truncus arteriosus but in many cases should
be described as common arterial trunk (CAT) (Kirby, 2008). The
mechanistic relationship between the SHF and the septation
process has been unclear.
Retinoic acid (RA) is a vitamin A derivative that is widely used
in development as a signaling molecule. Mouse embryos lacking
the major RA synthetic enzyme Raldh2 show a profound disrup-
tion of the SHF starting as early as E7.5 (Ryckebusch et al., 2008;
Sirbu et al., 2008). This indicates an early role for RA in delimiting
the domain of mesoderm that is competent to become the SHF.
In this study, we show that RA signaling also has a later and
distinct role in the further recruitment of splanchnic mesoderm
to a SHF fate. Our results suggest a specific effect on the subdo-
main known as the secondary heart field, which normally
contributes the distal myocardium of the outflow tract and the
mesodermal portion of smooth muscle of the great vessels
(Buckingham et al., 2005; Dyer and Kirby, 2009; Choudhary
et al., 2009). This secondary heart field deficiency in RA receptor
null embryos results in a shortened outflow tract and thereby in
alignment defects. As a related consequence, the tissue of the
shortened outflow tract is misspecified along its proximal-distal
axis at the time when septation is initiated. We show that the
CAT septation defect is a consequence of outflow tract axial
misspecification, one that results specifically from altered
TGFb signaling.RESULTS
Temporal Requirement for RA and RA Receptor Activity
RA signals are received by a heterodimer of one RAR and one
RXR, which are members of the nuclear receptor family.
Embryos lacking the a1 isoform of the RARa gene plus all iso-
forms of the RARb gene (RARa1/RARb) have common arterial
trunk (CAT) with 100% penetrance (Lee et al., 1997). Similarly,
embryos lacking RARa1 and all isoforms of the RXRa gene
(RARa1/RXRa) have CAT with high, although not full,Inc.
Table 1. Outflow Tract Phenotypes in RA Receptor Mutant Embryos
(A) Tamoxifen Treatment of CAGG-Cre,RARa1/,RXRaflox/flox Embryos
Injection time Mutants Litters CAT DORV Overriding Aorta Normal
E6.75–7.0 14 5 7 50% 3 21% 1 7% 3 21%
E7.5–8.0 17 7 5 29% 2 12% 2 12% 8 47%
E8.5 10 5 2 20% 2 20% 2 20% 4 40%
E9.0–9.5 17 8 0 0% 7 41% 4 24% 6 35%
E10.0–10.5 6 4 0 0% 0 0% 0 0% 6 100%
(B) Tissue-Specific Inactivation in Cre,RARa1/,RXRaflox/flox Embryos
Cre line Mutants Litters CAT DORV Overriding Aorta Normal
Mesp1Cre 18 11 9 50% 3 17% 3 17% 3 17%
Myf5Cre 8 2 0 0% 0 0% 0 0% 8 100%
Mef2cCre 10 8 0 0% 0 0% 0 0% 10 100%
Tie2Cre 7 3 0 0% 0 0% 0 0% 7 100%
(C) Rescue of Septation in RARa1/RARb Mutants by Reduction of TGFb2 Gene Dosage
Genotype Mutants Litters CAT DORV Overriding Aorta Normal
RARa1/RARb/ * * * 100% 0 0% 0 0% 0 0%
RARa1/RARb/TGFb2-/+ 9 7 4 44% 5 55% 0 0% 0 0%
(A)CAGG-Cre,RARa1/, RXRaflox/flox embryos were isolated following a single i.p. tamoxifen injection at the indicated times, and analyzed for cardio-
vascular defects.
(B) Phenotypes were scored in RARa1/,RXRaflox/flox embryos carrying the indicated Cre genes.
(C) Phenotypes were scored in double-receptor mutant embryos with or without heterozygosity of Tgfb2. *The complete penetrance of CAT in
RARa1/RARb embryos is based on some embryos from the current study plus many from earlier analyses, totaling over 100 embryos in all.
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shorter and right-sided, which is suggestive of a SHF deficiency.
To address the temporal requirement for RA receptor function,
wemade use of the Tg(CAGG-Cre/Esr1) transgenic line, in which
a tamoxifen-dependent version of Cre recombinase is ubiqui-
tously expressed. In CAGG-Cre-expressing conditional RXRa
embryos, RXRa protein is mostly eliminated by 24 hr following
a single injection of tamoxifen (see Figure S1A available online),
consistent with previous applications of CAGG-Cre to other
conditional gene targets (Hayashi and McMahon, 2002;
Xu et al., 2005). We crossed the CAGG-Cre transgene into a
background of germline RARa1 deficiency combined with a
conditional RXRa allele. In control embryos that lacked the Cre
gene or were wild-type for the RXRa gene, or in embryos that
were not treated with tamoxifen, there was no incidence of
OFT defects. In tamoxifen-treated Cre/RARa1/RXRa embryos,
a range of phenotypes was recovered (Table 1A). Disruption of
RA signaling at any time prior to E9.5 (i.e., treatment at E8.5 or
earlier) resulted in embryos with a right-sided common arterial
trunk and in additional embryos with alignment defects but
with normal septation. The range of phenotypes might reflect
variability in the extent of RXRa gene recombination as well as
the variability in phenotype seen in germline RARa1/RXRa
mutants. Importantly, the presence of functional RA receptors
prior to E9.0 was not sufficient to support normal OFT develop-
ment if the receptors were eliminated thereafter. Disruption of RA
signaling after E10.5 did not cause any OFT phenotype. These
observations, plus those described below, bracket the critical
time when these RA receptors function in OFT development to
the period approximately from E9.0–E10.5.
The RARE-lacZ transgene contains a multimerized RA re-
sponse element (RARE) coupled to a heterologous basalDevelopromoter and acts as an in vivo sensor for the presence of RA
and RA receptors. X-gal staining of normal RARE-lacZ trans-
genic embryos (Figures 1A–1C) revealed that endogenous levels
of RA sufficient to activate the transgene are present widely in
E8.75 and E9.5 embryos, including the splanchnic mesoderm
where the SHF is located. Staining in E10.5 and E11.5 embryos
was noticeably absent from the splanchnicmesoderm (Figure 1C
and data not shown). As described previously (Moss et al., 1998)
and in our results (data not shown), there was only limited
RARE-lacZ staining in the outflow tract itself at E10.5, and no
expression at E11.5, although significant reexpression occurs
at E12.5. This pattern is consistent with a role for retinoic acid
in SHF development during the period prior to E10.5, although
not directly with the process of OFT septation, which occurs at
E11.0–11.5.
Spatial Requirement for RA Receptor Activity
We previously showed that RA receptor function in the neural
crest cell lineage was not required for normal outflow tract devel-
opment (Jiang et al., 2002). To define the tissue specificity of RA
signaling, we crossed the RARE-lacZ transgene into the RARa1/
RARb mutant background. In E9.5 mutant embryos, staining
was compromised selectively in the splanchnic mesoderm (Fig-
ures 1Dand1E). In contrast, endodermal response toRA (Figures
1D and 1E), and Hox and Cyp26 gene expression (Figure S2A)
were unchanged, similarly, most aspects of pharyngeal develop-
ment are normal in RARa1/RARb mutants (Lee et al., 1997).
These observations indicate that theRARa1/RARbmutant back-
ground selectively interferes with mesodermal RA signaling.
We made use of conditional mutagenesis to further define the
specificity of RA signaling. The recombination pattern achieved
by each line when crossed with the conditional reporter allelepmental Cell 18, 480–485, March 16, 2010 ª2010 Elsevier Inc. 481
Figure 1. Visualization of Endogenous RA Response
(A–C) X-gal stained sections of normal RARE-lacZ transgenic embryos are
shown at E8.75, E9.5, and E10.5 in transverse section.
(D–E) Sagittal sections of control (D) and RARa1/RARb mutant (E) littermate
embryos at E9.5. Brackets indicate the splanchnic mesoderm (SpM). A, atria;
en, endoderm; OFT, outflow tract; V, ventricle; arrowheads, OFT myocardium.
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Cre allele was crossed with the conventional RARa1 mutation
and the conditional RXRa allele, and E14 embryos were
evaluated for heart and outflow tract morphology. The early-
acting and mesoderm-specific Mesp1Cre allele caused a high
frequency of outflow tract septation and alignment defects
(Table 1B). These results confirm a mesodermal requirement
for RA signaling in OFT development. Mef2c(AHF)Cre (hereafter
referred to asMef2cCre) drives recombination specifically in the
second heart field, Tie2Cre is specific for endothelium and endo-
cardium, and Myf5Cre is expressed in paraxial but not
splanchnic mesoderm. There was no cardiovascular phenotype
when any of these three Cre lines were crossed with the RARa1/
RXRa alleles (Table 1B). Both Mef2cCre and Tie2Cre are
sufficiently active to cause OFT defects when crossed to other
conditional genes (Gu et al., 2003; McCulley et al., 2008), so
normal OFT development in our study cannot likely be attributed
to ineffective recombination efficiency. The conclusion from this
analysis is that RA receptor function occurs within the recombi-
nation domain ofMesp1Cre, but occurs earlier in the differentia-
tion sequence or outside of the spatial domain of the tissues
defined by the other Cre lines. In fact, as described below, RA
signaling is required to activate Mef2c expression within the
progenitors of the second heart field.
Retinoic Acid Controls Renewal
of the Second Heart Field
SHF progenitors express Islet-1 (Isl1) and Nkx2.5. Based on
these markers (Figures 2A–2D; Figure S2B) and Fgf8 expression
(Figure S2C), the allocation and distribution of the SHF progen-482 Developmental Cell 18, 480–485, March 16, 2010 ª2010 Elsevieritor population was normal in RARa1/RARb mutants. Mef2c is
regulated by Isl1 and Nkx2.5 (Dodou et al., 2004; Tanaka et al.,
1999) and is induced in committed albeit still multipotent SHF
cells that will contribute to the ends of the outflow and inflow
tracts (Verzi et al., 2005) (Figures 2G–2R). Mef2cCre/R26R is a
validated surrogate forMef2c gene expression during the period
and in the tissues relevant for this study (Verzi et al., 2005). In
normal embryos through the E8.5–10.5 interval, the Mef2cCre/
R26R-positive SHF extends fully between the outflow and inflow
tracts (brackets in Figures 2I, 2M, and 2Q). A comparable pattern
was seen at E8.5 in RARa1/RARb mutants (Figure 2J) as in
normal controls, and the length of the OFT in E8.5 mutants
was normal as well (Figures 2G and 2H), indicating the normal
initial differentiation of the SHF. However, the Mef2c+ SHF pop-
ulation was severely diminished in E9.5 RARa1/RARb mutants
(Figure 2N; see also Figure S2C), and at E10.5, there was no
Mef2cCre/R26R staining of the splanchnic mesoderm in mutant
embryos (Figure 2R). Proliferation and apoptosis were both
normal in the mutant splanchnic mesoderm at E8.5 and E9.5
(Figure S2D). Because Mef2c-expressing cells migrate to the
heart tube, we infer that the absence of Mef2c expression in
the splanchnic mesoderm in mutant embryos starting at E9.5
represents a failure to replace early Mef2c+ cells that move
into the outflow tract. The deficiency in the Mef2c+ SHF explains
the shortened and ultimately right-sided outflow tract seen in
RAR mutants. This model also explains why Mef2cCre did not
cause OFT defects in conditional RARa1/RXRa mutants (Table
1B): RA signaling is needed in order to activate Mef2cCre in
the domain of the SHF that will be added to the outflow tract at
E9.0–10.5, but once Mef2c is activated, there is no longer
a continuing need for RA signaling (at least through RARa1 and
RXRa) to maintain the committed phenotype of these cells.
Indeed, the Mef2cCre/R26R staining pattern was unchanged in
conditionalMef2cCre/RARa1/RXRa/R26R embryos (Figure S2E).
GATA factors are known to regulateMef2c expression (Dodou
et al., 2004), and Gata4 has been previously implicated as a ret-
inoic acid-responsive gene (Arceci et al., 1993; Ghatpande et al.,
2000). Interestingly, GATA4 expression in RARa1/RARbmutants
was compromised in the same domain of the SHF that was lack-
ing Mef2c activity (compare Figures 2E and 2F, 2M and 2N).
A recent report documented rotation of the outflow tract as
SHF cells are added to the arterial pole and suggested that failure
of rotation may cause alignment and septation defects (Bajolle
et al., 2006; Bajolle et al., 2008). Using Sema3c as a marker, we
did not observe a rotation defect in RAR mutant embryos
(Figure S2F). We also previously described normal rotation of
neural crest cell mesenchyme in the OFT of mutant embryos
(Jiang et al., 2002). It therefore appears that interruption of accre-
tion of tissue to the outflow tract in RAR mutants does not inter-
fere with the rotation of tissue that has been added previously.
Deficient SHF Recruitment Results
in Improper OFT Specification
We observed no difference between control and mutant
embryos in expression of several markers (aSA, MF20, SM22,
SMA) that are expressed throughout the outflow tract at E9.5–
10.5 (Figures S3A–S3H). However, we did note that the distal
OFT displayed inappropriate proximal character, as defined by
the myocardial marker myosin light chain 2v (MLC2v) (FiguresInc.
Figure 2. Markers of the SHF
Littermate pairs were analyzed for expression of Isl1 (E10.5; [A and B]), Nkx2.5Cre/R26R (E9.75; [C and D]), GATA4 (E9.5; [E and F]), and Mef2cCre/R26R (G–R).
Asterisks, caudal portion of the SHF. Related images are in Figure S2.
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mesodermal cells in mutants (Figures 2N and 2R) arrests the
recruitment of SHF cells to the OFT, and thereby causes previ-
ously committed cells to be retained more distally in the OFT.Figure 3. OFT Axial Misspecification and Elevated TGFb Cause CAT
(A and B) Ectopic expression of the proximal markerMLC2v in the distal OFT of
RAR mutant embryos at E10.5.
(C and D) Endocardial mesenchyme (arrowheads) in the distal OFT of mutant
embryos at E10.5, visualized by Tie2Cre/R26R. Gray lines in (A)–(D) are posi-
tioned at the 90 bend between the proximal and distal segments of the OFT.
(E and F) Elevated Tgfb2 expression in the distal OFT in mutants at E9.75.
(G–I) Rescue of septation defects in E14.5 RAR mutants by reduced Tgfb2
gene dosage: a normal control embryo (G), a RARa1/RARb mutant with CAT
(H), and a RARa1/RARb mutant also heterozygous for Tgfb2 (I). In rescued
embryos, OFT septation occurs but both outflow vessels originate from the
right ventricle (the RV source of the ascending aorta is not seen in this panel).
Ao, ascending aorta; PT, pulmonary trunk. See also Figure S3.
DeveloIn the proximal and distal OFT, cushions form by infiltration of
mesenchymal cells between the endocardium and myocardium.
In normal embryos, neural crest-derived mesenchymal cells
migrate throughout the cushions, whereas mesodermal cells
derived by endocardial mesenchymal transformation (EMT) are
located only in the proximal cushions. We previously showed
that the number, migration, and differentiation of neural crest
cells was normal in RARa1/RARb mutant embryos (Jiang et al.,
2002). However, Tie2Cre/R26R revealed endocardium-derived
mesenchymal cells in the distal segment of the OFT (Figures
3C and 3D), where such cells are not normally found, and corre-
sponding to the territory where MLC2v was ectopically ex-
pressed. Thus, in mutant embryos, tissue that should normally
become proximal OFT is retained in the distal OFT, and the
process of endocardial EMT that normally occurs in the proximal
OFT also extends into the distal OFT.Altered TGFb Signaling Accounts for Septation Defects
but Not Alignment Defects in RAR Mutants
TGFb2 was a likely candidate to explain the ectopic endocar-
dium-derived mesenchyme in RAR mutants: TGFb promotes
endocardial EMT in vitro (Eisenberg and Markwald, 1995),
Tgfb2 is expressed by the myocardium in regions of EMT,
Tgfb2 null mutants are defective in OFT development (Sanford
et al., 1997), and TGFb expression is inversely associated with
RA signaling in other contexts (Kubalak et al., 2002; Chen et al.,
2007). Indeed, we found that Tgfb2 expression was elevated in
RAR mutants in the distal segment of the outflow tract (Figures
3E and 3F; Figure S3I).
To address whether elevated TGFb was related to any of the
OFT phenotypes, we combined RARa1/RARb deficiency with
heterozygosity of TGFb2. CAT is a 100% penetrant phenotype
in RARa1/RARb mutants, and in all such embryos, the single
OFT originates from the right ventricle (i.e., the OFT is shortenedpmental Cell 18, 480–485, March 16, 2010 ª2010 Elsevier Inc. 483
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dosage, normal septation was restored in half of the embryos
(Table 1C, Figures 3G–3I). Importantly, SHF defects (e.g.,
absenceofMef2cCre/R26R staining in the splanchnicmesoderm
and ectopic expression of MLC2v in the distal outflow tract;
Figures S3J–S3K) were unchanged by reduced Tgfb2 gene
dosage.Consequently, in all caseswhere septationwas rescued,
the ascending aorta always originated from the right ventricle and
DORV was the resultant phenotype (Table 1C, Figure 3I).DISCUSSION
Our results demonstrate that the OFT phenotype of RAR
mutants—a combination of a deficiency in outflow tract length-
ening and a failure in septation—results from two independent
processes that can be distinguished temporally, genetically,
and molecularly. The underlying requirement for RA signaling in
the E9.0–10.5 period is to promote the recruitment and commit-
ment of Isl1+, Nkx2.5+ progenitors to a Mef2c+ fate, in order to
replace previously specified Mef2c+ cells as they migrate into
the OFT and terminally differentiate. As a direct consequence
of the disruption of this process in RAR mutants, the OFT is
shortened and ultimately right-sided. For lack of accretion of
additional tissue to the end of the OFT, the tissue in the distal
OFT retains a proximal identity that is evidenced by expression
of the proximal genesMLC2v and Tgfb2 and by ectopic mesen-
chymal transformation of the endocardium. Misexpression of
Tgfb2 is causative specifically for compromised septation.
Our study visualizes the dynamic nature of SHF and OFT
development. Isl1+,Nkx2.5+ progenitors continually generate
Mef2c+ cells, probably starting as early as E7.5 but clearly
continuing through E10.5. Mef2c expression does not charac-
terize a self-renewing progenitor population, since despite a
relatively high proliferation rate, it does not renew itself as devel-
opment proceeds, at least to a level sufficient for the needs of
outflow tract morphogenesis. RA signaling through RARa1/
RARb and RARa1/RXRa is specifically associated with the later
(E9.0–10.5) differentiation of the Mef2c+ population.
The secondary heart field has been defined in chick embryos
as the splanchnic mesodermal subdomain of the SHF between
the outflow and inflow tracts that is restricted in fate to conotrun-
cal myocardium and smooth muscle of the outflow vessels, but
does not contribute to the right ventricle or atria (Buckingham
et al., 2005; Dyer and Kirby, 2009). In RARa1/RARb mutants,
the SHF contribution to the right ventricle and to the atrial
chambers was normal, based on morphological criteria and as
visualized using Mef2cCre/R26R. The selective defect in what
we suggest to be the secondary heart field was apparent by
the absence of Mef2cCre/R26R staining in the splanchnic
mesoderm of E9.5 and E10.5 mutant embryos. A recent report
described the expression of transgenes in subdomains of the
mouse SHF that are added relatively late to the outflow tract
(Bajolle et al., 2008), which may correspond to the same territory
as is missing in our RAR mutants. Our studies therefore lend
support to the distinct identity of the secondary heart field
in mammalian embryos, and demonstrate the importance of
RA signaling for its derivation from splanchnic mesodermal
progenitors.484 Developmental Cell 18, 480–485, March 16, 2010 ª2010 ElsevierOur observations indicate that GATA4, a known regulator of
Mef2c expression (Dodou et al., 2004), is not expressed in
RARa1/RARb mutants in the same territory that is deficient in
Mef2c expression (Figures 2E and 2F, 2M and 2N). Indeed, there
are several similarities between the RAR-deficient and GATA-
deficient phenotypes. Combined Gata4/Gata6 double knockout
did not impact the initial appearance of the Isl1+ and Nkx2.5+
splanchnic mesoderm at E8.5 (Zhao et al., 2008), just as in
RARa1/RARb mutants (Figures 2A–2D; Figure S2B). Germline
Gata4 null mutants die too early to evaluate their ultimate outflow
tract phenotype, but Gata4 hypomorphs have DORV (Crispino
et al., 2001; Pu et al., 2004), a clear indication that GATA4 is
required in SHF development. Similarly, combined heterozy-
gosity of Gata4 and Gata6 together results in a single outflow
vessel (CAT) (Xin et al., 2006), which is a completely penetrant
phenotype in RARa1/RARb mutants. These observations are
consistent with a model of Gata4 as a downstream target of
RA action that converges with Isl1 and Nkx2.5 to regulate
Mef2c expression and thereby to regulate differentiation of the
secondary heart field.
In the absence of differentiation of additional progenitors to a
Mef2c+ fate, the cells normally fated to be the proximal OFT
remain as the distal segment of what will ultimately be a short-
ened and right-sided outflow tract. These cells express the
proximal markersMLC2v and Tgfb2. Our results therefore imply
that specification of outflow tract axial patterning occurs in the
splanchnic mesoderm, and not after the second heart field cells
have become incorporated into the outflow tract and begun
differentiation. A previous study reached similar conclusions
based on the expression of marker transgenes (Bajolle et al.,
2008).
Our results show that ectopic expression of TGFb in the
outflow tract specifically accounts for septation defects, at least
in RARa1/RARb mutants. Although we suggest that ectopic
endocardial EMT contributes to septation failure, it remains
possible that the effects of TGFb on neural crest cells in the
outflow tract (Choudhary et al., 2006) are also relevant. The rela-
tive importance and role of endocardium-derived and neural
crest-derived mesenchyme in the overall process of outflow
tract septation remains to be clarified.EXPERIMENTAL PROCEDURES
Standard procedures were used for histology, X-gal staining, whole-mount
and section in situ hybridization, immunohistochemistry, and western blotting.
Detailed Experimental Procedures and a description of mouse lines used in
this study are provided as Supplemental Information.
Tamoxifen-Induced Temporal Gene Knockout
Pregnant females were treated with a single i.p. dose of 75 mg/kg tamoxifen
(Sigma, T5648) dissolved in corn oil. For phenotype analysis, females were
treated at defined time points and embryos isolated at E14.5, fixed in formal-
dehyde and embedded in paraffin, and analyzed histologically. For analysis of
RXRa protein, females were treated at E8.5 and whole embryos were isolated
at defined times thereafter and individually homogenized in 40 ml 250 mM
sucrose, 5 mM HEPES 7.5, 1 mM EGTA using a minipestle in a microfuge
tube, then an equal volume of 23 SDS-containing sample buffer was added
and the mixture boiled. Homogenates of paired littermate conditional RXRa
embryos that either carried or did not carry the CAGG-Cre transgene were
then subjected to SDS-PAGE and transferred to PVDFmembranes; antibodies
were from Santa Cruz (SC-553 and SC-47778).Inc.
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Embryos were isolated at E14.5, fixed and embedded in paraffin, and
sectioned and hematoxylin and eosin stained by standard procedures. CAT
was defined by a single outflow vessel (common arterial trunk) that originated
from the right ventricle. In this study, there were no examples of a common
arterial trunk positioned over the interventricular septum. In embryos where
septation had occurred, the position of the aortic outflow determined the diag-
nosis of DORV (from the right ventricle), overriding aorta (from a position over
the ventricular septum), or normal (from the left ventricle). All embryos with
CAT, DORV, or overriding aorta also had a ventricular septal defect, which is
a hemodynamic requirement of these phenotypes.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at doi:10.1016/j.devcel.2009.12.019.
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